Ophthalmic Drugs

Memo

As Europe’s leading Ophthalmic Drugs conference, we will explore new discoveries in the treatment of ocular rare disease, innovations in gene therapy, the challenges in drug delivery through a complex barrier, patient comfort, and regulatory compliance which make up such core components within the Ophthalmic Drug sphere. This three-day agenda offers you peer-to-peer networking with Global Product Managers, Heads of Drug Development, Senior Directors of Ophthalmology, Heads of Research and Development and many more. Prices:Conference Only: GBP 1499.0,Focus Day and Conference: GBP 2398.0 Time: 9:00 am - 5:00 pm